Biology of Transforming Growth Factor-β Signaling

被引:47
|
作者
Ikushima, Hiroaki [1 ]
Miyazono, Kohei [1 ]
机构
[1] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Tokyo 1130033, Japan
关键词
TGF-beta; Smad; non-Smad; cell proliferation; fibrosis; EMT; EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; TGF-BETA; CRYSTAL-STRUCTURE; C-MYC; MEDIATED DEGRADATION; NEGATIVE REGULATORS; CELLULAR-RESPONSES; TUMOR-SUPPRESSOR; SMAD PROTEINS;
D O I
10.2174/138920111798808419
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor (TGF)-beta signaling has been implicated as an important regulator of almost all major cell behaviors, including proliferation, differentiation, cell death, and motility. Which cell responses are induced or suppressed in response to TGF-beta depends on the cell type and the context in which TGF-beta signaling is received. TGF-beta ligands, their receptors, and intracellular Smad effectors lie in the center of TGF-beta signaling. TGF-beta ligands signal via receptor serine/threonine kinases that phosphorylate and activate Smad proteins as well as other signaling molecules. Smad complexes associate with chromatin and regulate transcription, defining the biological response of a cell to TGF-beta stimulation. In addition, numerous factors constitute complex networks to regulate TGF-beta signaling and to provide this cytokine with the ability to induce cellular context-specific cell responses. Perturbation of the network is strongly involved in various pathological situations, including cancer and fibrosis. In this review, we consider the basic machinery of TGF-beta signaling and describe several factors which make up TGF-beta signaling networks. We also address major TGF-beta-induced cell responses involved in several physiological and pathological conditions, including cell proliferation, fibrosis, and epithelial-mesenchymal transition.
引用
收藏
页码:2099 / 2107
页数:9
相关论文
共 50 条
  • [1] Transforming growth factor-β signaling in cancer
    Rich, JN
    Borton, AJ
    Wang, XF
    [J]. MICROSCOPY RESEARCH AND TECHNIQUE, 2001, 52 (04) : 363 - 373
  • [2] Targeting transforming growth factor-β signaling
    Pennison, Michael
    Pasche, Boris
    [J]. CURRENT OPINION IN ONCOLOGY, 2007, 19 (06) : 579 - 585
  • [3] Transforming growth factor-β signaling and cirrhosis
    Wrana, JL
    [J]. HEPATOLOGY, 1999, 29 (06) : 1909 - 1910
  • [4] Transforming growth factor-β and breast cancer: Transforming growth factor-β/SMAD signaling defects and cancer
    Marcus Kretzschmar
    [J]. Breast Cancer Research, 2
  • [5] Transforming growth factor-β and breast cancer -: Transforming growth factor-β/SMAD signaling defects and cancer
    Kretzschmar, M
    [J]. BREAST CANCER RESEARCH, 2000, 2 (02) : 107 - 115
  • [6] Transforming growth factor-β:: Biology and clinical relevance
    Kim, IY
    Kim, MM
    Kim, SJ
    [J]. JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 38 (01): : 1 - 8
  • [7] The Smad pathway in transforming growth factor-β signaling
    Haiyan Lin
    Hongmei Wang
    Cheng Zhu
    [J]. Science in China Series C: Life Sciences, 2003, 46 : 449 - 463
  • [8] Transforming growth factor-β signaling and ubiquitinators in cancer
    Glasgow, Eric
    Mishra, Lopa
    [J]. ENDOCRINE-RELATED CANCER, 2008, 15 (01) : 59 - 72
  • [9] Transforming growth factor-β signaling in systemic sclerosis
    Nolan B.Ayers
    Chenming Sun
    Shi-You Chen
    [J]. The Journal of Biomedical Research, 2018, 32 (01) : 3 - 12
  • [10] Transforming Growth Factor-β Signaling in Immunity and Cancer
    Batlle, Eduard
    Massague, Joan
    [J]. IMMUNITY, 2019, 50 (04) : 924 - 940